PHARMAKON ADVISORS, LP

Adviser information for PHARMAKON ADVISORS, LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 12
Investment Advisory/Research 7
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 5 $3.1B
Non-Discretionary 0 $0
Total 5 $3.1B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 4 $1.8B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 1 $1.3B
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 80

Services

Advisory Services Portfolio management for pooled investment vehiclesPORTFOLIO MANAGEMENT FOR A PUBLIC INVESTMENT TRUST
Compensation % of AUMPerformance-based fees

Identifiers

SEC RIA File Number 801-74263
SEC ERA File Number 801-74263
SEC CIK Numbers None
SEC CRD Numbers 161150
Legal Entity Identifier None

Principal Office

110 EAST 59TH STREET
28TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 9:00 AM - 6:00 PM
Tel: 212-883-2296, Fax: 917-210-4048

Chief Compliance Officer

DOUGLAS Y. KIM
SENIOR VICE PRESIDENT, HEAD OF LEGAL
110 EAST 59TH STREET, 28TH FLOOR
NEW YORK
NY
United States
Tel: (212) 883-6799
Fax: (917) 210-4048
(Full email address available in API data)

Regulatory Contact

JEFFREY CAPRIO
CONTROLLER
110 EAST 59TH STREET, 28TH FLOOR
NEW YORK
NY
United States
Tel: (212) 883-2263
Fax: (917) 210-4048
(Full email address available in API data)

Industry Affiliates

BIOPHARMA CREDIT INVESTMENTS V GP LLC Sponsor, GP, manager of pooled investment vehicles
PHARMA MANAGEMENT (CAYMAN) LTD. Sponsor, GP, manager of pooled investment vehicles
PHARMACEUTICAL INVESTORS, LP Sponsor, GP, manager of pooled investment vehicles
RP MANAGEMENT IRELAND LTD. Other investment adviser, including financial planners
RP MANAGEMENT, LLC Other investment adviser, including financial planners
RPI EPA HOLDINGS, LP Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
BIOPHARMA CREDIT INVESTMENTS V (MASTER) LP Private Equity Fund $1,818.9M $0.0M 163

Control Persons

Name Type Entity Title Since Ownership
GONZALEZ DE COSIO, PEDRO, NMN Individual CHIEF EXECUTIVE OFFICER, LIMITED PARTNER 04/2009 25-50%
LEGORRETA, PABLO, GERARDO Individual LIMITED PARTNER 04/2009 25-50%
FRIEDMAN, MARTIN, GERSHON Individual LIMITED PARTNER 01/2013 25-50%
PHARMAKON MANAGEMENT I LLC Domestic Entity GENERAL PARTNER 04/2009 25-50%
GONZALEZ DE COSIO, PEDRO, NMN Individual PHARMAKON MANAGEMENT I LLC MANAGING MEMBER 04/2009 50-75%
LEGORRETA, PABLO, GERARDO Individual PHARMAKON MANAGEMENT I LLC MANAGING MEMBER 04/2009 50-75%
KIM, DOUGLAS, YEON Individual CHIEF COMPLIANCE OFFICER 09/2022 < 5%

No. Employees, Historic

2010020192020202120222023202420257 on 4/12/20198 on 3/27/20208 on 5/13/202010 on 3/30/202110 on 5/10/202110 on 3/29/202210 on 10/7/202211 on 3/31/202311 on 4/12/202312 on 3/28/2024

RAUM, Historic

4B2B020192020202120222023202420251906070143 on 4/12/20191827841416 on 3/27/20201900309416 on 5/13/20202200874959 on 3/30/20212200874959 on 5/10/20212299401587 on 3/29/20222299401587 on 10/7/20222895267795 on 3/31/20232895267795 on 4/12/20233128821083 on 3/28/2024

No. Clients, Historic

20100201920202021202220232024202511 on 4/12/20198 on 3/27/20208 on 5/13/202010 on 3/30/202110 on 5/10/20216 on 3/29/20226 on 10/7/20226 on 3/31/20236 on 4/12/20235 on 3/28/2024